Cannabigerol (CBG) is a cannabinoid found in the cannabis plant. Often referred to as the “mother cannabinoid,” CBG is the precursor to better-known compounds like cannabidiol (CBD) and tetrahydrocannabinol (THC). As the plant matures, CBG is naturally converted into these other cannabinoids, which is why only small amounts remain in most cannabis strains.
Although CBG is present in smaller quantities, early studies suggest it interacts with CB1 and CB2 receptors, as well as other receptors in the body. It’s being explored for potential anti-inflammatory, antibacterial, and neuromodulatory properties, however, research is still in the early stages, and its medical applications are not yet fully understood.
CBG is considered a promising compound within medical cannabis research. It does not produce intoxication and is being studied for its possible role in supporting conditions that require multi-targeted approaches.
